Pharma Journalist -

Ono and Jorna Launch Collaboration on Novel RNA Editing Therapies

Ono and Jorna Launch Collaboration on Novel RNA Editing Therapies

Roche to Invest $50B in U.S. Pharma and Diagnostics Over 5 Years

uniQure’s AMT-130 Gets FDA Breakthrough Tag for Huntington’s

DAAN Biotherapeutics and GC Cell Sign Deal to Transfer Tumor Antigen Antibody Tech for Next-Gen CAR-T/NK Therapies

Dupixent Approved in U.S. as First Targeted Therapy in Over a Decade for Chronic Hives

BigHat and Lilly Team Up to Develop AI-Driven Antibody Therapies

Cellino and Karis Bio Partner to Develop First Nebula-Powered iPSC Therapy for Heart Disease

Boehringer Ingelheim and Cue Biopharma Team Up on Next-Gen Autoimmune Therapies

EU Approves Roche’s Columvi as First Bispecific Antibody for DLBCL After Initial Treatment

Pfizer Shares Update on Oral GLP-1 Candidate Danuglipron